Krister Wennerberg

According to our database, Krister Wennerberg authored at least 18 papers between 2012 and 2023.

Collaborative distances:

• Dijkstra number of four.
• Erdős number of four.

2023

Breeze 2.0: an interactive web-tool for visual analysis and comparison of drug response data.

Potdar Swapnil, Filipp Ianevski, Aleksandr Ianevski, ZiaurRehman Tanoli, Krister Wennerberg, Brinton Seashore-Ludlow, Olli-P. Kallioniemi, Päivi Östling, Tero Aittokallio, Saarela Jani

Nucleic Acids Res., July, 2023

2022

Minimal information for chemosensitivity assays (MICHA): a next-generation pipeline to enable the FAIRification of drug screening experiments.

ZiaurRehman Tanoli, Jehad Aldahdooh, Farhan Alam, Yinyin Wang, Umair Seemab, Maddalena Fratelli, Petr Pavlis, Marián Hajdúch, Florence Bietrix, Philip Gribbon, Andrea Zaliani, Matthew D. Hall, Min Shen, Kyle R. Brimacombe, Evgeny Kulesskiy, Saarela Jani, Krister Wennerberg, Markus Vähä-Koskela, Jing Tang

Briefings Bioinform., 2022

2021

Exploration of databases and methods supporting drug repurposing: a comprehensive survey.

ZiaurRehman Tanoli, Umair Seemab, Andreas Scherer, Krister Wennerberg, Jing Tang, Markus Vähä-Koskela

Briefings Bioinform., 2021

Network-guided identification of cancer-selective combinatorial therapies in ovarian cancer.

Liye He, Daria Bulanova, Jaana Oikkonen, Antti Häkkinen, Kaiyang Zhang, Shuyu Zheng, Wenyu Wang, Erdogan Pekcan Erkan, Olli Carpén, Titta Joutsiniemi, Sakari Hietanen, Johanna Hynninen, Kaisa Huhtinen, Sampsa Hautaniemi, Anna Vähärautio, Jing Tang, Krister Wennerberg, Tero Aittokallio

Briefings Bioinform., 2021

2020

Breeze: an integrated quality control and data analysis application for high-throughput drug screening.

Potdar Swapnil, Aleksandr Ianevski, John-Patrick Mpindi, Dmitrii Bychkov, Clément Fiere, Philipp Ianevski, Bhagwan Yadav, Krister Wennerberg, Tero Aittokallio, Olli-P. Kallioniemi, Saarela Jani, Päivi Östling

Bioinform., 2020

Interactive visual analysis of drug-target interaction networks using Drug Target Profiler, with applications to precision medicine and drug repurposing.

ZiaurRehman Tanoli, Zaid Alam, Aleksandr Ianevski, Krister Wennerberg, Markus Vähä-Koskela, Tero Aittokallio

Briefings Bioinform., 2020

2019

Prediction of drug combination effects with a minimal set of experiments.

Aleksandr Ianevski, Anil K. Giri, Prson Gautam, Alexander Kononov, Potdar Swapnil, Saarela Jani, Krister Wennerberg, Tero Aittokallio

Nat. Mach. Intell., 2019

2018

Global proteomics profiling improves drug sensitivity prediction: results from a multi-omics, pan-cancer modeling approach.

Mehreen Ali, Suleiman A. Khan, Krister Wennerberg, Tero Aittokallio

Bioinform., 2018

Drug Target Commons 2.0: a community platform for systematic analysis of drug-target interaction profiles.

ZiaurRehman Tanoli, Zaid Alam, Markus Vähä-Koskela, Balaguru Ravikumar, Alina Malyutina, Alok Jaiswal, Jing Tang, Krister Wennerberg, Tero Aittokallio

Database J. Biol. Databases Curation, 2018

2017

Computational-experimental approach to drug-target interaction mapping: A case study on kinase inhibitors.

Anna Cichonska, Balaguru Ravikumar, Elina Parri, Sanna Timonen, Tapio Pahikkala, Antti Airola, Krister Wennerberg, Juho Rousu, Tero Aittokallio

PLoS Comput. Biol., 2017

Systematic identification of feature combinations for predicting drug response with Bayesian multi-view multi-task linear regression.

Muhammad Ammad-ud-din, Suleiman A. Khan, Krister Wennerberg, Tero Aittokallio

Bioinform., 2017

2015

Impact of normalization methods on high-throughput screening data with high hit rates and drug testing with dose-response data.

John-Patrick Mpindi, Potdar Swapnil, Dmitrii Bychkov, Saarela Jani, Khalid Saeed, Krister Wennerberg, Tero Aittokallio, Päivi Östling, Olli-P. Kallioniemi

Bioinform., 2015

TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples.

Liye He, Krister Wennerberg, Tero Aittokallio, Jing Tang

Bioinform., 2015

2014

Making Sense of Large-Scale Kinase Inhibitor Bioactivity Data Sets: A Comparative and Integrative Analysis.

Jing Tang, Agnieszka Szwajda, Sushil Kumar Shakyawar, Tao Xu, Petteri Hintsanen, Krister Wennerberg, Tero Aittokallio

J. Chem. Inf. Model., 2014

Integrative and Personalized QSAR Analysis in Cancer by Kernelized Bayesian Matrix Factorization.

Muhammad Ammad-ud-din, Elisabeth Georgii, Mehmet Gönen, Tuomo Laitinen, Olli-P. Kallioniemi, Krister Wennerberg, Antti Poso, Samuel Kaski

J. Chem. Inf. Model., 2014

Identification of structural features in chemicals associated with cancer drug response: a systematic data-driven analysis.

Suleiman A. Khan, Seppo Virtanen, Olli-P. Kallioniemi, Krister Wennerberg, Antti Poso, Samuel Kaski

Bioinform., 2014

2013

Target Inhibition Networks: Predicting Selective Combinations of Druggable Targets to Block Cancer Survival Pathways.

Jing Tang, Leena Karhinen, Tao Xu, Agnieszka Szwajda, Bhagwan Yadav, Krister Wennerberg, Tero Aittokallio

PLoS Comput. Biol., 2013

2012

Comprehensive data-driven analysis of the impact of chemoinformatic structure on the genome-wide biological response profiles of cancer cells to 1159 drugs.

Suleiman A. Khan, Ali Faisal, John Mpindi, Juuso A. Parkkinen, Tuomo Kalliokoski, Antti Poso, Olli-P. Kallioniemi, Krister Wennerberg, Samuel Kaski

BMC Bioinform., 2012